 |
R&D
|
Overview and Mission
Research and Development at Boehringer Ingelheim Pharmaceuticals, Inc. was established in 1979. With a focus on cardiovascular and immunological/inflammatory diseases, Boehringer Ingelheim Pharmaceuticals, Inc. continues to be a world leader in discovering and developing novel therapies for human disease. By providing highly qualified employees with the best possible facilities and equipment to achieve their goals, Boehringer Ingelheim enables researchers to accelerate the discovery and screening process for potential human therapies.
Boehringer Ingelheim Pharmaceuticals is committed to significantly impacting quality of life issues for patients and caregivers through ongoing and innovative research. This hard work and dedication has contributed to Boehringer Ingelheim being reconginzed as one of the highest in worldwide growth.